Department of Paediatrics, Burton Hospitals NHS Foundation Trust, Queen's Hospital, Burton-upon-Trent, Staffordshire, UK.
J Clin Pathol. 2010 Jul;63(7):652-4. doi: 10.1136/jcp.2009.074617. Epub 2010 May 24.
Epidemiology and resistance patterns of bacterial pathogens in paediatric urinary tract infections (UTIs) show large inter-regional variability, and rates of bacterial resistance are changing due to different antibiotic treatment. Empiric therapy to treat UTI should be tailored to the surveillance data on the epidemiology and resistance patterns of common uropathogens to reduce treatment failures and emergence of bacterial resistance within the community.
A retrospective data review was carried out to evaluate the resistance patterns to commonly used antibiotics in children with culture proven UTIs.
All infants and children with culture proven UTI from 2002 to 2008 were included. Urine culture was deemed positive with a pure growth >10(5) (single organism).
A total of 547 UTIs were confirmed on urine cultures in 337 patients. An average of 78 cases were diagnosed each year. E coli was the most commonly grown pathogen (92%). From 2002 to 2008, rising resistance patterns were noted for trimethoprim (p<or=0.05) and Augmentin (p<or=0.001). In contrast, resistance to cefalexin and nitrofurantoin remained relatively low (11% and 7%, respectively, in 2008).
Our data suggest that there has been an increasing resistance trend to the first-line antibiotics like trimethoprim and Augmentin against E coli. In accordance with NICE (National Institute for Health and Clinical Excellence) guidance, each region should monitor resistance patterns to urinary pathogens on a regular basis and use antibiotics with a low resistance pattern. Further studies are required from other centres in the UK to look at similar data.
儿科尿路感染(UTI)的细菌病原体的流行病学和耐药模式存在很大的区域差异,并且由于不同的抗生素治疗,细菌耐药率正在发生变化。经验性治疗UTI 应根据常见尿路病原体的流行病学和耐药模式监测数据进行调整,以减少治疗失败和社区内细菌耐药性的出现。
对经培养证实的 UTI 患儿常用抗生素的耐药模式进行回顾性数据分析。
纳入 2002 年至 2008 年间经培养证实为 UTI 的所有婴儿和儿童。尿液培养被认为是阳性的,其纯生长>10(5)(单一生物体)。
在 337 名患者中,共有 547 例 UTI 通过尿液培养得到证实。平均每年诊断出 78 例病例。大肠埃希菌是最常见的病原体(92%)。从 2002 年到 2008 年,Trimethoprim(p<0.05)和 Augmentin(p<0.001)的耐药模式呈上升趋势。相比之下,头孢氨苄和呋喃妥因的耐药率仍然相对较低(2008 年分别为 11%和 7%)。
我们的数据表明,针对大肠埃希菌的一线抗生素如 Trimethoprim 和 Augmentin 的耐药趋势有所增加。根据 NICE(国家卫生与临床卓越研究所)的指导,每个地区都应定期监测尿路病原体的耐药模式,并使用耐药模式较低的抗生素。英国其他中心需要进一步研究以查看类似数据。